Zillios is the next generation international real estate platform, revolutionary and highly innovative. Zillios completely changes the way the real estate market operates providing a state of the art scalable infrastructure to all key stakeholders, including smart contract based features to tackle current inefficiencies in rental and buying processes. Blockchain-based property transfer is foreseen in Zillios´ technology providing a future-proof infrastructure.

Emrify is launching a decentralized Personal Health Record platform on top of the Ethereum public blockchain to deliver trusted health information to the right hands at the right time anywhere in the world. With years of building consumer engagement mobile apps, Emrify is laser focused on collecting and locking up data for each person for complete ownership and control to freely share their data. Our top priority is to create attractive cryptoeconomics models to incentivize health data sharing for all parties. With strategic US partnerships with hospitals and doctors, Emrify is building on top of established prototypes to accelerate the launch of production interfaces to firmly establish the Utility Token in healthcare.

DocTailor is a unique self customizing smart legal contract platform, that allows, lawyers, individuals and organizations to send and create legal tailor-made smart contracts and agreements on the blockchain without developer experience.Bridging the gap between the trillion dollar crypto economy market.

Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.

Expected to kick off in 2018, the Fan-Controlled Football League (FCFL) reimagines American football – and the experience of being a die-hard fan – for the digital age. The FCFL will seek to deliver a compelling football product that captivates a broader digital audience. It will feature fast-paced, high-scoring action that embraces the spread-football evolution of the NCAA football and NFL games while enabling a diverse set of styles and strategies on both offense and defense ─ all controlled by the fans. Player personnel and real-time play calling decisions are all made by fans via the league’s blockchain platform, making fans the coach and general manager for their team. Fans will no longer be just viewers; rather, they will be active contributors to the games they are watching. This is a transformational shift in the way sports fans engage and interact: no more sitting back and passively watching as a team’s roster takes shape or a game unfolds. They will be essential to the league’s product both on the field and off. This is the democratization of sports, and it’s about to be realized through the most innovative sports league ever created, thanks to decentralized blockchain technology.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.